Active Ingredient Ustekinumab
Active Ingredient Details
What is Ustekinumab?
A humanized monoclonal antibody that binds to IL-12 and IL-23 and is used as a DERMATOLOGIC AGENT in the treatment of patients with plaque PSORIASIS who have not responded to other therapies.
What is the usage for Ustekinumab?
Ustekinumab is used to treat plaque psoriasis, a certain type of arthritis (psoriatic arthritis), or certain bowel conditions (Crohn's disease, ulcerative colitis). It works by blocking certain natural proteins in your body (interleukin-12 and interleukin-23) that cause inflammation (swelling) in these conditions. Ustekinumab does not cure these diseases, but helps to lessen symptoms of the disease. It can help to decrease the amount of plaques in plaque psoriasis, decrease the number of swollen/painful joints in psoriatic arthritis, and decrease symptoms such as abdominal pain/cramping and diarrhea in Crohn's disease and ulcerative colitis.
How many products in the NDC database contain Ustekinumab?
The NDC database has 45 products with the active ingredient Ustekinumab. The following table lists all the products that have this active ingredient.
NDC Products with Ustekinumab
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
---|---|---|---|---|---|---|---|
51407-929 | Proprietary Name: Imuldosa | Ustekinumab-srlf | Injection | Subcutaneous | Golden State Medical Supply, Inc. | ACTIVE | |
51407-930 | Proprietary Name: Imuldosa | Ustekinumab-srlf | Injection | Subcutaneous | Golden State Medical Supply, Inc. | ACTIVE | |
51407-931 | Proprietary Name: Imuldosa | Ustekinumab-srlf | Injection | Intravenous | Golden State Medical Supply, Inc. | ACTIVE | |
57894-054 | Proprietary Name: Stelara | Ustekinumab | Solution | Intravenous | Janssen Biotech, Inc. | ACTIVE | |
57894-060 | Proprietary Name: Stelara | Ustekinumab | Injection, Solution | Subcutaneous | Janssen Biotech, Inc. | ACTIVE | |
57894-061 | Proprietary Name: Stelara | Ustekinumab | Injection, Solution | Subcutaneous | Janssen Biotech, Inc. | ACTIVE | |
57894-440 | Proprietary Name: Ustekinumab | Ustekinumab | Injection, Solution | Subcutaneous | Janssen Biotech, Inc. | ACTIVE | |
57894-441 | Proprietary Name: Ustekinumab | Ustekinumab | Injection, Solution | Subcutaneous | Janssen Biotech, Inc. | ACTIVE | |
57894-444 | Proprietary Name: Ustekinumab | Ustekinumab | Solution | Intravenous | Janssen Biotech, Inc. | ACTIVE | |
61314-651 | Proprietary Name: Pyzchiva | Ustekinumab-ttwe | Injection, Solution | Subcutaneous | Sandoz Inc | ACTIVE | |
61314-652 | Proprietary Name: Pyzchiva | Ustekinumab-ttwe | Injection, Solution | Subcutaneous | Sandoz Inc | ACTIVE | |
61314-654 | Proprietary Name: Pyzchiva | Ustekinumab-ttwe | Injection, Solution | Intravenous | Sandoz Inc | ACTIVE | |
64538-824 | Proprietary Name: | Ustekinumab-aauz | Injection | Rentschler Biopharma Se | ACTIVE | ||
65219-824 | Proprietary Name: Otulfi | Ustekinumab-aauz | Injection, Solution | Subcutaneous | Fresenius Kabi Usa, Llc | ACTIVE | |
65219-826 | Proprietary Name: Otulfi | Ustekinumab-aauz | Injection, Solution | Subcutaneous | Fresenius Kabi Usa, Llc | ACTIVE | |
65219-828 | Proprietary Name: Otulfi | Ustekinumab-aauz | Solution | Intravenous | Fresenius Kabi Usa, Llc | ACTIVE | |
65267-896 | Proprietary Name: | Ustekinumab | Injection | Janssen Pharmaceutical Sciences Unlimited Company | ACTIVE | ||
68225-250 | Proprietary Name: | Ustekinumab-ttwe | Injection, Solution | Patheon Italia S.p.a | ACTIVE | ||
68225-251 | Proprietary Name: | Ustekinumab-ttwe | Injection, Solution | Patheon Italia S.p.a | ACTIVE | ||
68225-253 | Proprietary Name: | Ustekinumab-ttwe | Injection, Solution | Patheon Italia S.p.a | ACTIVE | ||
69448-017 | Proprietary Name: Imuldosa | Ustekinumab-srlf | Injection | Subcutaneous | Accord Biopharma Inc. | ACTIVE | |
69448-018 | Proprietary Name: Imuldosa | Ustekinumab-srlf | Injection | Subcutaneous | Accord Biopharma Inc. | ACTIVE | |
69448-019 | Proprietary Name: Imuldosa | Ustekinumab-srlf | Injection | Intravenous | Accord Biopharma Inc. | ACTIVE | |
70383-130 | Proprietary Name: | Ustekinumab | Injection, Solution, Concentrate | Bioconnection B.v. | ACTIVE | ||
72606-027 | Proprietary Name: Steqeyma | Ustekinumab-stba | Injection, Solution | Subcutaneous | Celltrion Inc. | ACTIVE | |
72606-028 | Proprietary Name: Steqeyma | Ustekinumab-stba | Injection, Solution | Subcutaneous | Celltrion Inc. | ACTIVE | |
72606-029 | Proprietary Name: Steqeyma | Ustekinumab-stba | Injection, Solution | Intravenous | Celltrion Inc. | ACTIVE | |
82009-160 | Proprietary Name: Ustekinumab-ttwe | Ustekinumab-ttwe | Injection, Solution | Subcutaneous | Quallent Pharmaceuticals Health Llc | ACTIVE | |
82009-162 | Proprietary Name: Ustekinumab-ttwe | Ustekinumab-ttwe | Injection, Solution | Subcutaneous | Quallent Pharmaceuticals Health Llc | ACTIVE | |
82009-163 | Proprietary Name: Ustekinumab-ttwe | Ustekinumab-ttwe | Injection, Solution | Intravenous | Quallent Pharmaceuticals Health Llc | ACTIVE | |
82507-004 | Proprietary Name: | Ustekinumab | Solution | Agc Biologics A/s | ACTIVE | ||
83257-023 | Proprietary Name: Yesintek | Ustekinumab | Injection, Solution | Subcutaneous | Biocon Biologics Inc. | ACTIVE | |
83257-024 | Proprietary Name: Yesintek | Ustekinumab | Injection, Solution | Subcutaneous | Biocon Biologics Inc. | ACTIVE | |
83257-025 | Proprietary Name: Yesintek | Ustekinumab | Injection, Solution | Subcutaneous | Biocon Biologics Inc. | ACTIVE | |
83257-026 | Proprietary Name: Yesintek | Ustekinumab | Solution | Intravenous | Biocon Biologics Inc. | ACTIVE | |
83457-651 | Proprietary Name: Pyzchiva | Ustekinumab-ttwe | Injection, Solution | Subcutaneous | Cordavis Limited | ACTIVE | |
83457-652 | Proprietary Name: Pyzchiva | Ustekinumab-ttwe | Injection, Solution | Subcutaneous | Cordavis Limited | ACTIVE | |
83457-654 | Proprietary Name: Pyzchiva | Ustekinumab-ttwe | Injection, Solution | Intravenous | Cordavis Limited | ACTIVE | |
84612-055 | Proprietary Name: Wezlana | Ustekinumab-auub | Injection, Solution | Subcutaneous | Optum Health Solutions (ireland) Limited | ACTIVE | |
84612-066 | Proprietary Name: Wezlana | Ustekinumab-auub | Injection, Solution | Intravenous | Optum Health Solutions (ireland) Limited | ACTIVE | |
84612-076 | Proprietary Name: Wezlana | Ustekinumab-auub | Injection, Solution | Subcutaneous | Optum Health Solutions (ireland) Limited | ACTIVE | |
84612-089 | Proprietary Name: Wezlana | Ustekinumab-auub | Injection, Solution | Subcutaneous | Optum Health Solutions (ireland) Limited | ACTIVE | |
84612-855 | Proprietary Name: Wezlana | Ustekinumab-auub | Injection, Solution | Subcutaneous | Optum Health Solutions (ireland) Limited | ACTIVE | |
84612-876 | Proprietary Name: Wezlana | Ustekinumab-auub | Injection, Solution | Subcutaneous | Optum Health Solutions (ireland) Limited | ACTIVE | |
84612-889 | Proprietary Name: Wezlana | Ustekinumab-auub | Injection, Solution | Subcutaneous | Optum Health Solutions (ireland) Limited | ACTIVE |